Irazu Oncology, LLC — Form D
Irazu Oncology, LLC of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-14. The offering totals $3.9M, of which $2.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-14
- Form: D
- Accession: 0002004491-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.9M
- Amount sold: $2.6M
- Remaining: $1.3M
- Investors: 6
- Date of first sale: 2023-11-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-499692
Issuer
- Name: Irazu Oncology, LLC
- CIK: 0002004491
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 801 W. BALTIMORE STREET, BALTIMORE, MD, 21201
- Phone: 443-396-8689
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| JAMES BERENS | Executive Officer | LAGUNA HILLS, CA |
| Richard Kohr | Executive Officer | Baltimore, MD |
More